GlassScriptPhysician profile
Avnish Tripathi
NPI 1801150214
$13,109.16
in general payments reported to CMS, 2019-2025
38 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,717 · 2020: $917 · 2021: $862 · 2022: $1,196 · 2023: $1,228 · 2024: $1,850 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,058 · Food and Beverage: $2,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,057.60 |
| Food and Beverage | $2,359.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,229.96 | 2021-2025 | Advisa Dr Mri Surescan, Venaseal, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $1,230.30 | 2019-2023 | |
| Terumo Medical Corporation | $1,163.90 | 2019-2024 | Angio-Seal |
| Boston Scientific Corporation | $789.49 | 2020-2025 | Rotapro, Avvigo Guidance System, Synergy |
| Abbott Laboratories | $777.05 | 2021-2023 | Perclose Prostyle |
| Abiomed | $338.02 | 2022-2025 | Impella |
| Janssen Pharmaceuticals, INC | $303.31 | 2019-2022 | |
| Cardiovascular Systems INC. | $277.53 | 2019-2022 | |
| Medtronic Vascular, INC. | $276.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $250.72 | 2020-2025 | |
| Avinger INC. | $245.60 | 2022 | |
| Inari Medical, INC. | $228.95 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.31 | 2020-2025 | Lifevest |
| Amgen INC. | $198.56 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $159.75 | 2020-2024 | Eliquis |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $145.78 | 2019-2025 | Lokelma |
| Novo Nordisk INC | $137.54 | 2021-2024 | Ozempic, Wegovy |
| Chiesi USA, INC. | $136.03 | 2019-2022 | |
| Penumbra, INC. | $130.54 | 2022-2024 | Penumbra Coil 400, Indigo System |
| Cordis US Corp. | $109.82 | 2022-2024 | Mynx Control |
| Amarin Pharma, INC. | $100.16 | 2019-2021 | |
| Shockwave Medical, INC | $82.70 | 2021-2025 | |
| Pfizer INC. | $78.64 | 2022-2023 | |
| Edwards Lifesciences Corporation | $77.86 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals International, Plc | $74.22 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $66.87 | 2022-2023 | Verquvo |
| Baxter Healthcare | $44.35 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $42.03 | 2021 | |
| Heartflow, INC. | $34.11 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.47 | 2022 | |
| Ekos Corporation | $25.70 | 2019 | |
| Irhythm Technologies, INC. | $18.27 | 2023 | Zio Xt Patch |
| Teleflex LLC | $17.78 | 2024 | Supercross |
| Sanofi-Aventis U.S. LLC | $17.74 | 2022 | |
| Stryker Corporation | $15.67 | 2025 | Clottriever Bold Catheter |
| Lexicon Pharmaceuticals, INC. | $14.80 | 2023 | Inpefa |
| Cook Medical LLC | $14.57 | 2019 | |
| Lundbeck LLC | $12.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avnish Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.